Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hoodia gordonii is a succulent plant from the Kalahari Desert containing the bioactive compound P57 (oxypregnane steroidal glycoside). P57 works by mimicking glucose's effect on hypothalamic neurons to suppress appetite signals in the brain.
Origin & History
Hoodia gordonii is a succulent plant native to the Kalahari Desert region of southern Africa, belonging to the Apocynaceae family. The ingredient is derived from plant stems through a standardized extraction process involving harvesting, comminution, drying under controlled conditions, and extraction using food-grade solvents, yielding an extract containing 73.7% steroidal glycosides.
Research Narrative (Provisional)
The provided research dossier does not contain specific human clinical trials, randomized controlled trials (RCTs), or meta-analyses with PubMed PMIDs evaluating Hoodia gordonii's efficacy. The available sources focus on chemical characterization and manufacturing processes rather than clinical outcomes.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
{"macronutrients": {"carbohydrates": "Not specified", "proteins": "Not specified", "fats": "Not specified"}, "micronutrients": {"vitamins": "Not specified", "minerals": "Not specified"}, "bioactive_compounds": {"P57": "Concentration not specified, known for appetite suppression"}, "bioavailability_notes": "Limited data on nutritional content and bioavailability; primarily studied for appetite suppressant properties."}
Reported Mechanism (Provisional)
The primary bioactive compound P57 (oxypregnane steroidal glycoside) mimics glucose's action on ATP-sensitive potassium channels in hypothalamic neurons. This triggers the same satiety signals that occur after eating, leading to reduced food intake. P57 appears to work specifically on the ventromedial hypothalamus, the brain's primary appetite control center.
Clinical Narrative (Provisional)
Clinical evidence for hoodia remains extremely limited despite widespread marketing claims. No large-scale randomized controlled trials have been published demonstrating significant weight loss or appetite suppression in humans. Most available research consists of in vitro studies and animal models showing P57's effects on hypothalamic neurons. The lack of robust human clinical data makes it impossible to quantify hoodia's actual effectiveness for appetite control or weight management.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.